Single Cell Genomics Market Assessment

Single Cell Genomics Market Assessment


Single cell genomics (SCG) is a fast growing, emerging approach in which genomic technologies (i.e., that assess nucleic acids such as DNA or RNA) are applied at the level of single cells, rather than at the level of an entire cell population. The third edition of this report reviews the market size, segmentation, growth and trends of the SCG market. We assess the SCG market across 7 segments and 33 subsegments: customer (e.g., academia, biopharma, applied markets, clinical), workflow step (e.g., cell isolation, sample preparation, genomic analysis), analytical technology (e.g., PCR, qPCR, microarray, next-generation-sequencing, other), field-of-study (e.g., oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other), application (e.g., genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation / reprograming, method, other), product type (e.g., instruments, reagents) and geography (e.g., U.S., Europe, Japan, China, Asia-Pacific, ROW). For each of these segments, we provide an estimated market size and growth from 2013 to 2021, as well as key growth drivers and moderators. Special analysis conducted in this report includes the categorization of ~1,400 SCG peer-reviewed publications from 2010 to Feb 2017.


Author: Miguel Edwards

Date: May 5, 2017

Pages: 117 pages

Price: $5500

  • Select SCG Companies

  • Major Trends
    • Increasing competition, putting pressure on the market to innovate
    • Availability of new platforms that streamline the historically laborious and low throughput workflow
    • Growth in the number of SCG centers, core facilities, and service providers expanding the geographical footprint of SCG
    • Development of new protocols and reagents optimized to improve the single-cell DNA/RNA amplification
    • Adoption of SCG by new customers segments
    • Remaining workflow challenges, including isolating cells from tissue and recovering DNA / RNA at a high yield, amplifying DNA / RNA with limited bias and downstream computational analysis
    • Lack of short-term clinical applications
  • Report Segmentations

    Buyers of SCG instruments, reagents, and consumables from manufacturers

    • Academia
    • Biopharma
    • Clinical
    • Applied Markets
    • Others

    Type of a platform that manufacturer sells to its customers, based on throughout

    • Microbiology
    • Basic cell biology
    • Stem cell biology
    • Oncology
    • Immunology
    • Non-specific
    • Other

    Country / region of the world

    • U.S.
    • Europe
    • Japan
    • China
    • Asia Pacific (APAC)
    • Rest-of-the-world (ROW)

    Individual steps in the SCG analysis process starting from sample and ending with data

    • Single cell isolation
    • Sample preparation
    • Genomic analysis

    Key scientific research question being investigated

    • Subpopulation characterization
    • Genomic variation
    • Cell differentiation/ reprogramming
    • Method
    • Circulating cells
    • Others

    Companies that offer SCG products

    • Fluidigm
    • 10X Genomics
    • BioRad
    • Wafergen
    • Becton Dickinson
    • Mission Bio
    • Takara Clontech
    • Others

    Genomic technology used to quantify and / or identify the DNA / RNA of each single cell

    • qPCR
    • Sequencing
    • PCR
    • Multiple
    • Microarray
    • Other

    Type of product that manufacturer sells to its customers

    • Instruments
    • Reagents
  • Table of Contents
  • Related Reports


Miguel Edwards is a senior associate at DeciBio with over a decade of combined experience in life science business consulting and academic research. Miguel’s research and professional experience spans a variety of industries with a focus on disruptive technologies within life science research tools and diagnostics.
Miguel earned his Ph.D. in Molecular Biology at UCLA where he identified key signatures of stem cells and the impact of these on differentiation mechanisms. Miguel has extensive experience in genome engineering, and next generation sequencing across the entire workflow from library generation through computational analysis.

Connect with Miguel on LinkedIn today!